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Abstract
Background—With the decreasing cost and efficiency of next generation sequencing, the 
technology is rapidly introduced into clinical and public health laboratory practice.
Aims—In this review, the historical background and principles of first, second and third 
generation sequencing are described as are the characteristics of the most commonly used 
sequencing instruments.
Sources—Peer reviewed literature, white papers and meeting reports.
Content & implications—Next generation sequencing is a technology that potentially could 
replace many traditional microbiological workflows, providing clinicians and public health 
specialists with more actionable information than hitherto achievable. Examples of the clinical and 
public health uses of the technology are provided. The challenge of comparability of different 
sequencing platforms is discussed. Finally, the future directions of the technology integrating it 
with laboratory management and public health surveillance systems, and moving it towards 
performing sequencing directly from the clinical specimen (metagenomics) could lead to yet 
another fundamental transformation of clinical diagnostics and public health surveillance.
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Introduction
DNA sequencing technologies have existed since the early 1970’s, but initially their cost, 
complexity, and requirement for toxic or radioactive reagents limited their use to research 
settings. The chain-termination methods pioneered by Sanger and colleagues (1) was more 
practical, and formed the basis for the first generation of automated DNA sequencers. Public 
health applications were first introduced in the 1990’s, such as the multilocus sequence 
typing scheme for Neisseria meningitidis developed by Maiden et al. (2). The first complete 
genome of a free-living microorganism, Haemophilus influenza, published in 1995 (3) was 
sequenced using the Sanger method. However, whole genome sequencing (WGS) by this 
technology was prohibitively expensive, cumbersome, and time-consuming. The need for 
high throughput sequencing technology was intensified by initiation of the Human Genome 
Project (HGP) in 1990 and its goal to sequence and interpret the 3.2 billion nucleotide base 
pairs comprising the human genome for potential medical benefits. This 3.8 billion dollar 
international collaboration was initially based on Sanger sequencing(4, 5).A major change 
occurred in the early 2000’s, when new next generation sequencing (NGS) methods using 
massively parallel processing brought the cost down to a fraction of the cost of Sanger 
sequencing, and dramatically reduced sequencing time. During the 2010’s, WGS for 
bacterial pathogens began migrating from research laboratories into public health practice. 
The trend accelerated after several high profile infectious disease events, including the 
cholera epidemic in Haiti following the 2010 earthquake (6), and 2011 international 
outbreak of E. coli O104:H4 disease associated with fenugreek sprout consumption (7, 8). 
Both outbreaks involved significant morbidity and mortality, which created an urgent need to 
understand transmission dynamics and virulence characteristics. In both situations, 
government laboratories and academic institutions responded rapidly with NGS technology 
using open sharing of data and crowd sourcing. Adoption of NGS by public health 
laboratories has greatly accelerated since these outbreaks, and global implementation of 
standardized WGS for surveillance is now well under way in public health (9, 10) (http://
www.globalmicrobialidentifier.org/) and increasingly in bigger hospital laboratories.
One of the earliest applications of WGS in public health was teasing out epidemiological 
associations in hospital acquired infections, such as the 2010 outbreak of Acinetobacter 
baumannii in a British hospital (11). Within a few years, WGS began to be used more widely 
for elucidating and interrupting transmission pathways in hospital outbreaks, such as those 
caused by methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant 
Klebsiella pneumonia (12, 13). In these examples, WGS analyses were conducted from 
cultured isolates. As will be described later in this chapter, WGS has the potential for rapidly 
providing a large amount of information from isolates, including species, strain type, 
antibiotic resistance, virulence, and other information for outbreak and case management. 
While the value of WGS for outbreak detection and investigation is clear in many situations, 
at current cost levels the usefulness of this approach is less clear for diagnosis and treatment 
of individual patients, especially considering the emergence of direct-from-specimen multi-
analyte test panels. These tests have the ability to identify common pathogens in patient 
specimens in a highly useful timeframe (14).
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The most extensive implementation of WGS in public health has been in the area of 
surveillance of foodborne diseases, which are both common and preventable. Globally, an 
estimated 1.9 billion people acquire a foodborne infection, and 715,000 die each year (15). 
Outbreak surveillance helps identify why people become ill, so that prevention efforts can be 
more precisely directed. Molecular-based real-time surveillance programs such as PulseNet 
have been very effective at identifying contamination problems in widely distributed food 
commodities that would otherwise not have been detected. Using subtyping by Pulsed Field 
Gel Electrophoresis (PFGE), the PulseNet surveillance in the U.S. has resulted in the 
prevention of millions of illnesses and saved billions of dollars in healthcare costs and lost 
productivity (16). Early data from surveillance of listeriosis in the U.S.A. suggests that WGS 
can dramatically improve upon these numbers. The number of outbreaks detected increased 
36% after implementation of real-time WGS based surveillance, and likewise the number of 
solved outbreaks increased more than three-fold (figure 1) while the incidence of disease 
remained constant at approximately 0.2 cases per 100,000 (17). Similar improvements in 
surveillance of listeriosis were found in France after WGS implementation (18).
NGS can be a replacing technology since the information generated from multiple 
traditional workflows may be combined into a single efficient WGS workflow. For example, 
information about species, serotype, virulence characteristics, and antibiotic resistance can 
be extracted from genomes in addition to phylogenetically relevant subtyping information. 
Information about antimicrobial resistance and virulence characteristics could be used in 
clinical decision making although more data is needed on the correlation between genotype 
and phenotype before this may be used in clinical practice. .
Sequencing Technologies
The Sanger method (“first generation” technology) was the primary sequencing technology 
between 1975 and 2005. Sanger sequencing produces relatively long (500–1000 bp) high 
quality DNA sequences, and has long been considered the gold standard for sequencing 
DNA. The introduction of pyrosequencing technology by 454 Life Sciences in 2005 began 
the “next generation sequencing” (NGS) revolution (19). This high throughput technology 
allowed the generation and detection of thousands to millions of short sequencing reads in a 
single machine run without the need for cloning. Since then, many other NGS technologies 
have emerged that generate both short (50 – 400 bp) and long reads (1 – 100 kb). A brief 
description of the main platforms and their performance is provided below. More details can 
be found from some excellent recent reviews (20–22). A glossary of some commonly used 
sequencing terminology is provided in Table 1.
The short read technologies currently in use are collectively known as massively parallel 
sequencing and are often also referred to as second generation sequencing (23). They 
produce billions of nucleotide sequences during each run, where each genome is sequenced 
multiple times in small random pieces to generate very large datasets. Even though 
platforms have different biochemistry and arrays, the workflows include similar steps: i) 
DNA extraction; ii) library preparation, which usually includes shearing the DNA either 
mechanically or enzymatically, adding adaptors and barcodes/indexes, and amplification; iii) 
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template preparation, either by bridge amplification or emulsion PCR; and iv) automated 
sequencing (Figure 2)(22).
The short read sequencing platforms differ substantially in terms of their engineering, 
sequencing chemistry, output (length of reads, number of sequences), accuracy and cost 
(Table 2) (20). The Illumina platform, which currently occupies a vast part of the NGS 
market, is based on sequencing by synthesis of the complementary strand and fluorescence-
based detection of reversibly-blocked terminator nucleotides (24). The platform includes 
multiple instruments with varying throughput and read length (Table 2).
The MiniSeq and MiSeq instruments offer low to mid sample throughput, affordable 
instrument pricing, user-friendly workflow with no need for automation and reasonable per 
sample cost ($120 per 5 MB genome) and are hence an attractive choice for diagnostic and 
public health laboratories. The considerably more expensive NextSeq, HiSeq and NovaSeq 
instruments are designed for much higher throughput reducing the per sample cost, but 
require additional automation for library preparation and are therefore more appropriate for 
sequencing core facilities. Since the best cost efficiency can only be achieved by always 
making full capacity sequencing runs, the choice of the appropriate sequencing platform that 
is in tune with laboratory’s sample throughput is critical for real-time testing. For example, a 
single MiSeq instrument and sequencing with the v3 chemistry would cover real-time testing 
in a laboratory that annually processes 4000 isolates. Of all the available NGS technologies, 
the Illumina data, in particular data generated on the HiSeq, generates the highest quality 
base calls. The IonTorrent platform from Thermo Fisher is also based on sequencing by 
synthesis but the detection is based on solid state pH meters measuring hydrogen ions 
released during DNA polymerization (semiconductor technology) (25). The PGM and S5 
instruments are the IonTorrent equivalents for the Illumina MiniSeq and MiSeq; the Ion 
Proton is equivalent of Illumina NextSeq (Table 2). The instrument pricing is similar though 
the per sample cost is higher for the IonTorrent platform. Compared to the Illumina 
platform, the library prep process is lengthier for the IonTorrent though parts of it can be 
automated with the use of the IonChef sample preparation system. The IonTorrent 
sequencing run itself is much shorter (hours vs. days) compared to the Illumina instruments. 
The PGM and S5 reads are about 100 bp longer than the longest Illumina reads though only 
single-end reads can be generated. Because of the nature of the semiconductor sequencing, 
the IonTorrent platform has high error rate in base calls in long homopolymer regions. The 
short read platforms are commonly used for generating bacterial draft genomes for variant 
calling for diagnostics and infectious disease surveillance purposes. However, the lower 
throughput instruments are also well suited for targeted amplicon sequencing, such as 
detecting antimicrobial resistance determinants or 16S sequencing. Other applications 
include RNA sequencing to study the expression of genes and metagenomics sequencing 
(21).
Since the short reads from the second generation sequencing platforms tend to generate 
relatively fragmented genome assemblies, longer reads are desired in order to generate 
closed reference genomes. Longer reads are particularly useful when sequencing through 
complex genomic regions such as repeats and phages. Some phages can be up to 50–75 kB 
in length. To meet this demand, the so-called third generation sequencing platforms have 
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been introduced (23). These technologies directly target single DNA molecules without the 
need for PCR amplification. The PacBio RSII platform, marketed by Pacific Biosciences, 
uses single molecule real-time (SMRT) sequencing technology (26). As with short read 
technologies, sequencing is based on synthesis utilizing nucleotides labeled with distinct 
fluorescent dyes but sequencing proceeds when single stranded DNA molecules are 
deposited into tiny wells where a single DNA polymerase molecule is immobilized. 
Extremely long DNA fragments of 20 kb and even longer can be obtained with run times of 
only few hours. However, the run throughput is low and the per sample cost high which 
coupled with a high instrument cost and large footprint (Table 2) render the PacBio platform 
more suitable for sequencing core facilities that wish to generate high quality finished 
genomes. The platform, as with other long-read technology, has a higher inherent error 
profile (11–15%) than short read technologies, necessitating a subsequent assembly 
algorithm that relies on error correction(27). The error rate can be reduced by increasing the 
number of subreads generated. However, the number of sequencing passes and the read 
length are a trade-off, i.e. the higher the coverage, the shorter the reads. Pacific Biosciences 
recently released a higher throughput and more affordable version of RSII called Sequel. 
The MinION device developed by the Oxford Nanopore Technologies is another long read 
sequencing platform that currently is not as mature as the PacBio platform. With the size of 
a large thumb drive, it is the smallest sequencing device available. It can plug in to a 
standard USB-3 port on a computer with low hardware requirement and simple 
configuration. MinION is the first commercial sequencing platform utilizing Nanopore 
technology (28). It identifies DNA bases by measuring changes in electric conductivity 
generated as DNA strands pass through a biological pore. The read length profile of MinION 
is very similar to that of PacBio but the error rate is even higher (12–38 %) though it has 
been improving with recent advances in chemistry (29). The current version of MinION has 
difficulty in sequencing GC rich regions. Unlike PacBio, the error rate cannot be improved 
by increasing coverage since the MinION is limited to two sequencing passes by design. 
Similar to PacBio, complex assembly and error correction algorithms need to be employed 
in order to produce high quality assemblies (29, 30). The current throughput is low and not 
very stable and the default run time is 48 h though data can be analyzed in real-time as the 
reads pass through the sequencer. The portability and the real-time sequence analysis aspect 
make the MinION platform an attractive option for field diagnostics applications (31). 
Oxford Nanopore Technologies recently announced the availability of its new higher 
throughput platform PromethION through an early access program. There are 48 flow cells 
incorporated making it equivalent to 48 MiniIONs (29).
Analytical Approaches
One of the basic assumptions in molecular epidemiology is that phylogeny approximates 
epidemiology, i.e. patients are more likely to be epidemiologically associated if the 
pathogens that made them ill are closely related phylogenetically than if they are not. 
Similarly, if pathogens from food or the environment are phylogenetically related to clinical 
isolates a causal relationship between the two is likely. The generation of reproducible, 
phylogenetically meaningful data through sequence analysis is central to the practical 
application of sequence data for outbreak detection and investigation. However, like any 
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other subtyping or strain characterization method, this correlation between epidemiology 
and phylogeny is incomplete and sequencing data cannot stand on their own but should 
always be interpreted taking all available epidemiological and other supporting information 
into consideration.
A thorough description of bioinformatics and bioinformatic tools is the subject of another 
review in this series. For subtyping, two main high discriminatory phylogenetic approaches 
are used: high quality single nucleotide polymorphisms (hqSNP), and core genome/whole 
genome multilocus sequence typing (cg/wgMLST). A short introduction to the use of these 
approaches is given here. The hqSNP approach compares single nucleotide differences 
between isolates in comparison to one reference genome. This reference genome must be 
closely related to the isolates in the comparison to identify true phylogenetically informative 
SNPs for comparison. Results generated using different references and pipelines cannot 
directly be compared. Since the selection of the reference genome is difficult to standardize 
because almost all outbreaks need their own unique reference strain and there is no 
consensus about which of the many applications (pipelines) for hqSNP to use this method is 
not well suited for outbreak investigations performed at the same time in more laboratories. 
However, it is excellent for centralized analysis providing similar or better resolution 
between strains than wgMLST (9, 32, 33).
The cg/wg MLST approach is more universal. Whole genome (wg) MLST assesses the 
diversity of theoretically all genes in a particular genus or species (2). Core genome (cg) 
MLST assesses all the genes universally found in a particular genus or species (34, 35). New 
isolates are compared against a database of all known gene variants (an allele database) 
which may be used to assess the relatedness of all isolates belonging to the species it was 
developed for. An increasing number of such databases is being developed with some 
available in public domain (34–37) making the MLST approach uniquely suitable for multi 
laboratory outbreak investigations like the ones performed by the PulseNet networks (9).
In addition to subtyping, one consolidated WGS workflow could replace traditional 
characterization of pathogens, which require specialized skills and knowledge about each 
pathogen, expensive reagents, and complicated workflows with extensive quality control 
procedures. For example, current methods for full characterization of Shiga toxin-producing 
Escherichia coli (STEC) at the Centers for Disease Control and Prevention includes a 
number of phenotypic tests for species identification, ten PCR assays for virulence profiling, 
broth microdilution assays for antimicrobial susceptibility testing and agglutination assays 
with 270 pooled and individual O- and H-specific antisera for serotyping. The turn-around-
time for this characterization is routinely between one and three weeks. A WGS workflow 
can provide more detailed information than traditional methods in a matter of days. WGS 
workflows have also been used to successfully identify and characterize strains in clinical 
settings (11, 37).
The availability of analysis tools on the web that a microbiologist without extensive 
bioinformatic training can use for pathogen characterization has accelerated the 
characterization process. Examples of such tools for in silico analysis of bacterial WGS may 
be found on the Center for Genomic Epidemiology (CGE) web-site 
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(www.genomicepidemiology.org) (38–40). Among others, CGE provides virulence, 
resistance and serotype prediction tools (VirulenceFinder, ResFinder and SerotypeFinder) 
that can be used for analysis of Escherichia coli and other pathogenic bacteria (41–43). The 
CGE website also includes a pipeline in which multiple analyses can be performed on 
multiple batched sequences.
Since the 1960s DNA–DNA hybridization (DDH) has been the gold standard for species 
identification. In 1987, Wayne, et al. set a standard DDH similarity of 70% or greater for 
identification of strains to the same species (44). A WGS counterpart to DDH is Average 
Nucleotide Identity (ANI). This method assesses the nucleotide identity between genetic 
regions shared by two isolates and can unambiguously identify the species of a given isolate 
from its WGS. ANI values of approximately 95% correspond to 60–70% DDH values (45, 
46). Twenty-eight genomic sequences from Bacillus, Burkholderia, Escherichia/Shigella, 
Pseudomonas, Shewanella and Streptococcus were analyzed and all showed 95% or greater 
ANI values when compared to isolates of the same species (45). An ANI algorithm (ANIm) 
can identify the species of an isolate in a matter of seconds to minutes. ANIm is run using 
MUMmer software which includes a rapid whole genome aligner and may use multiple 
reference genomes as a reference database allowing a quick comparison of the query 
sequence (47).
Future needs and developments
The sequencing technology, bioinformatics and the informatics infrastructure are all rapidly 
evolving. Therefore, a number of changes are expected to happen within the next few years 
that greatly will affect the implementation of sequencing in routine clinical and public health 
microbiology.
It is a challenge that the comparability of the sequence data generated on different platforms 
with different error profiles using different library preparation methods has still not been 
comprehensively assessed and validated. Only a handful of studies with a limited number of 
species, isolates and analysis methods have been performed (48–50). Systematic studies that 
include strain identification, characterization and subtyping by both hqSNP and cg/wgMLST 
are badly needed. Internationally agreed standards for sequence and analysis quality, and 
data interpretation for clinical, public health and regulatory action are currently missing for 
most applications and must be developed.
On the positive side, the cost of sequencing, data transfer and analysis will continue to 
decrease and the DNA purification including library preparation and the actual sequencing 
will become faster and more efficient. The Achilles heel of the current long read 
technologies, the high error rates, will continue to improve until they become as precise as 
the short-read technologies at which time the latter will become obsolete. The routine 
closure of genomes by the long read technologies will facilitate backwards compatibility 
with current gold standard molecular subtyping methods like multilocus variable number of 
tandem repeats (MLVA) and PFGE ensuring that the historic information generated by these 
methods is not lost.
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Automation is critical for the routine use of the technology in clinical microbiology. 
Currently, the sequencing procedures are increasingly being automated in large clinical and 
public health laboratories. Standardized data handling and analysis is also being developed 
as on-line (www.genomicepidemiology.org; www.ncbi.nlm.nih.gov/pathogens/) or stand-
alone applications (9). The next step in the NGS evolution will be to integrate the two, 
sequencing and data analysis, in one efficient workflow. The user will load the bacterial 
culture/specimen into the DNA preparation module of the sequencer with no manual 
interaction until a standardized report customized to each laboratory’s needs has been 
generated and stored in a Laboratory Information Management System (LIMS) database. 
The report will include actionable strain characterization data for the clinicians, and 
subtyping information for public health. This change will revolutionize infection control and 
public health through providing data in real-time to detect clonal spread of pathogens or 
plasmids in hospitals, and outbreaks in hospitals or in the outside community.
In the longer term, the improved long read technology combined with more efficient IT 
capacity, nucleic acid enrichment technologies, and bioinformatics will enable routine 
implementation of metagenomics sequencing of specimens for non-culture clinical 
diagnostics, true real-time infection control and public health surveillance.
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Figure 1. 
Metrics illustrating the benefits of using WGS compared to PFGE for real-time outbreak 
laboratory surveillance for listeriosis in the United States
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Figure 2. 
Typical WGS workflow in a clinical or public health laboratory
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Table 1
Glossary of some commonly used sequencing terms
Adapter Any short piece of DNA of known sequence that one adds to the ends of their unknown DNA of interest, 
usually for the purpose of eventually allowing a sequencing primer to hybridise at this position
Amplicon sequencing Ultra-deep sequencing of PCR products for analyzing genetic variations
ANI Average nucleotide identity – An analysis method that assesses the nucleotide identity between genetic 
regions shared by two isolates
Assembly Genome assembly is the process by which many short DNA sequence fragments, such as those generated 
by next generation sequencers, are reassembled into a representation of the original genomic sequence
Bridge amplification A PCR technique that embeds DNA on a solid surface for sequencing. It is used by Illumina’s platforms
Contig A contiguous consensus sequence derived from the assembly of many short, overlapping DNA fragments
cgMLST Core genome multi-locus sequence typing - an analysis method that detects variation in genes that are 
present in the majority (>97%) of strains of a given species
Coverage (read depth) The average number of reads that include a given nucleotide in the reconstructed sequence
Draft genome Sequence of genomic DNA having lower accuracy than finished sequence; some segments are missing or 
in the wrong order or orientation
Emulsion PCR A PCR technique that is conducted on a bead surface within tiny water bubbles floating on an oil 
solution. It is used by IonTorrent platforms.
Error rate The per-read error rate is defined as the proportion of reads containing sequencing errors
Flow cell A glass slide containing small fluidic channels, through which polymerases, nucleotides and buffers can 
be pumped during sequencing
High quality SNP A single nucleotide polymorphism that has been verified using specific criteria such as: sequence 
coverage, sequence quality, and population and allelic frequency
Homopolymer A DNA sequence (2 or more base pairs) consisting of the same nucleotide
Index (barcode) Unique individual DNA sequences added to each sample so they can be distinguished and sorted during 
data analysis. Enables sequencing multiple samples per instrument run.
Massively parallel sequencing High throughput DNA sequencing approaches that use the concept of miniaturized massive parallel 
processing to sequence 1 million to 43 billion short reads per instrument run
Metagenomics The study of genetic material recovered directly from the primary samples
Paired-end reading Sequencer starts reading DNA fragment at one end, finishes this direction at the specified read length, 
and then starts another round of reading from the opposite end of the fragment
Per-base sequence quality 
(accuracy)
The sequence quality score for each individual base position in a sequence. Typically, phred scores are 
used, where Q = −10log (Error Probability). A Q30, for example, means a 1 in 1000 likelihood of an 
incorrect base call at that position.
Pyrosequencing Sequencing is performed by detecting the nucleotide incorporated using enzymatic reactions after which 
the substrate emits light
Read A unit of continuous DNA sequence derived from target DNA
Reversibly-blocked terminator A molecule added to a nucleotide to prevent addition of multiple nucleotides per sequencing cycle. Used 
by Illumina platforms.
Sanger sequencing A low throughput sequencing method based on the selective incorporation of chain-terminating 
dideoxynucleotides by DNA polymerase during in vitro DNA replication
Semiconductor sequencing Sequencing is performed by detection of hydrogen ions that are released during incorporation of the 
nucleotide. Used by IonTorrent platforms.
Sequencing by synthesis Sequencing is performed by detecting the nucleotide incorporated by a DNA polymerase
Single-end reading The sequencer reads a DNA fragment from only one end to the other, generating the sequence of base 
pairs
wgMLST Whole genome multi-locus sequence typing – an analysis method that detects variation in all genes (core 
and accessory genes) of a given genome
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